The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia

Young Seok Lee, Ho Cheol Kim, Bo Young Lee, Chang Keun Lee, Mi Young Kim, Se Jin Jang, Hye Sun Lee, Jieun Moon, Thomas V. Colby, Dong Soon Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BACKGROUND: Because of the highly variable clinical course of rheumatoid arthritis-associated usual interstitial pneumonia (RA-UIP), the prediction of patient prognosis is important.

OBJECTIVE: The aim of this study was to investigate the role of blood biomarkers as prognostic predictors in the patients with RA-UIP.

METHODS: The blood levels of biomarkers (Krebs von den Lungen-6 [KL-6], surfactant protein-A [SP-A], matrix metalloproteinase-7 [MMP-7], interleukin-6 [IL-6], and interleukin-32 [IL-32]) were retrospectively compared with the clinical courses of 62 patients with RA-UIP.

RESULTS: The median follow-up period was 33.4 months. RA-UIP progressed in 15 patients (45.2%) during one year of follow-up. We found that KL-6 and IL-6 were significant predictors of short-term (1 year) prognosis. Multivariate logistic regression analysis showed that the odds ratio (OR) for KL-6 was 1.001 (95% confidence interval [CI]: 1.000-1.003, p = 0.077) and that the OR for IL-6 was 1.040 (95% CI: 1.002-1.080, p = 0.039) for short-term disease progression. The addition of KL-6 and IL-6 to the clinical parameters (concordance index [C-index]: 0.958, p = 0.053) predicted short-term disease progression better than the clinical parameter alone (C-index: 0.853). In addition, patients with high levels of KL-6 (≥933 U/mL) had shorter survival than those with low levels of KL-6 (<933 U/mL) (median survival: 51 vs. 96 months, p = 0.019).

CONCLUSIONS: The results of this retrospective study suggested that KL-6 and IL-6 could be used as predictors of short-term disease progression. In addition, high levels of KL-6 could be used as a predictor of mortality. Additional studies involving a larger patient cohort are warranted.

Original languageEnglish (US)
Pages (from-to)216-223
Number of pages8
JournalSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Volume33
Issue number3
StatePublished - Oct 7 2016

Fingerprint

Idiopathic Pulmonary Fibrosis
Rheumatoid Arthritis
Biomarkers
Interleukin-6
Disease Progression
Odds Ratio
Matrix Metalloproteinase 7
Confidence Intervals
Pulmonary Surfactant-Associated Protein A
Survival
Interleukins
Retrospective Studies
Logistic Models
Regression Analysis
Mortality

Keywords

  • Biomarkers, Rheumatoid arthritis, Interstitial lung disease, Prognosis, KL-6, IL-6

ASJC Scopus subject areas

  • Internal Medicine
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia. / Lee, Young Seok; Kim, Ho Cheol; Lee, Bo Young; Lee, Chang Keun; Kim, Mi Young; Jang, Se Jin; Lee, Hye Sun; Moon, Jieun; Colby, Thomas V.; Kim, Dong Soon.

In: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, Vol. 33, No. 3, 07.10.2016, p. 216-223.

Research output: Contribution to journalArticle

Lee, Young Seok ; Kim, Ho Cheol ; Lee, Bo Young ; Lee, Chang Keun ; Kim, Mi Young ; Jang, Se Jin ; Lee, Hye Sun ; Moon, Jieun ; Colby, Thomas V. ; Kim, Dong Soon. / The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia. In: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 2016 ; Vol. 33, No. 3. pp. 216-223.
@article{03d32d7b4db344c1aeb2fc7731bc2cbd,
title = "The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia",
abstract = "BACKGROUND: Because of the highly variable clinical course of rheumatoid arthritis-associated usual interstitial pneumonia (RA-UIP), the prediction of patient prognosis is important.OBJECTIVE: The aim of this study was to investigate the role of blood biomarkers as prognostic predictors in the patients with RA-UIP.METHODS: The blood levels of biomarkers (Krebs von den Lungen-6 [KL-6], surfactant protein-A [SP-A], matrix metalloproteinase-7 [MMP-7], interleukin-6 [IL-6], and interleukin-32 [IL-32]) were retrospectively compared with the clinical courses of 62 patients with RA-UIP.RESULTS: The median follow-up period was 33.4 months. RA-UIP progressed in 15 patients (45.2{\%}) during one year of follow-up. We found that KL-6 and IL-6 were significant predictors of short-term (1 year) prognosis. Multivariate logistic regression analysis showed that the odds ratio (OR) for KL-6 was 1.001 (95{\%} confidence interval [CI]: 1.000-1.003, p = 0.077) and that the OR for IL-6 was 1.040 (95{\%} CI: 1.002-1.080, p = 0.039) for short-term disease progression. The addition of KL-6 and IL-6 to the clinical parameters (concordance index [C-index]: 0.958, p = 0.053) predicted short-term disease progression better than the clinical parameter alone (C-index: 0.853). In addition, patients with high levels of KL-6 (≥933 U/mL) had shorter survival than those with low levels of KL-6 (<933 U/mL) (median survival: 51 vs. 96 months, p = 0.019).CONCLUSIONS: The results of this retrospective study suggested that KL-6 and IL-6 could be used as predictors of short-term disease progression. In addition, high levels of KL-6 could be used as a predictor of mortality. Additional studies involving a larger patient cohort are warranted.",
keywords = "Biomarkers, Rheumatoid arthritis, Interstitial lung disease, Prognosis, KL-6, IL-6",
author = "Lee, {Young Seok} and Kim, {Ho Cheol} and Lee, {Bo Young} and Lee, {Chang Keun} and Kim, {Mi Young} and Jang, {Se Jin} and Lee, {Hye Sun} and Jieun Moon and Colby, {Thomas V.} and Kim, {Dong Soon}",
year = "2016",
month = "10",
day = "7",
language = "English (US)",
volume = "33",
pages = "216--223",
journal = "Sarcoidosis Vasculitis and Diffuse Lung Diseases",
issn = "1124-0490",
publisher = "Mattioli 1885 S.p.A.",
number = "3",

}

TY - JOUR

T1 - The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia

AU - Lee, Young Seok

AU - Kim, Ho Cheol

AU - Lee, Bo Young

AU - Lee, Chang Keun

AU - Kim, Mi Young

AU - Jang, Se Jin

AU - Lee, Hye Sun

AU - Moon, Jieun

AU - Colby, Thomas V.

AU - Kim, Dong Soon

PY - 2016/10/7

Y1 - 2016/10/7

N2 - BACKGROUND: Because of the highly variable clinical course of rheumatoid arthritis-associated usual interstitial pneumonia (RA-UIP), the prediction of patient prognosis is important.OBJECTIVE: The aim of this study was to investigate the role of blood biomarkers as prognostic predictors in the patients with RA-UIP.METHODS: The blood levels of biomarkers (Krebs von den Lungen-6 [KL-6], surfactant protein-A [SP-A], matrix metalloproteinase-7 [MMP-7], interleukin-6 [IL-6], and interleukin-32 [IL-32]) were retrospectively compared with the clinical courses of 62 patients with RA-UIP.RESULTS: The median follow-up period was 33.4 months. RA-UIP progressed in 15 patients (45.2%) during one year of follow-up. We found that KL-6 and IL-6 were significant predictors of short-term (1 year) prognosis. Multivariate logistic regression analysis showed that the odds ratio (OR) for KL-6 was 1.001 (95% confidence interval [CI]: 1.000-1.003, p = 0.077) and that the OR for IL-6 was 1.040 (95% CI: 1.002-1.080, p = 0.039) for short-term disease progression. The addition of KL-6 and IL-6 to the clinical parameters (concordance index [C-index]: 0.958, p = 0.053) predicted short-term disease progression better than the clinical parameter alone (C-index: 0.853). In addition, patients with high levels of KL-6 (≥933 U/mL) had shorter survival than those with low levels of KL-6 (<933 U/mL) (median survival: 51 vs. 96 months, p = 0.019).CONCLUSIONS: The results of this retrospective study suggested that KL-6 and IL-6 could be used as predictors of short-term disease progression. In addition, high levels of KL-6 could be used as a predictor of mortality. Additional studies involving a larger patient cohort are warranted.

AB - BACKGROUND: Because of the highly variable clinical course of rheumatoid arthritis-associated usual interstitial pneumonia (RA-UIP), the prediction of patient prognosis is important.OBJECTIVE: The aim of this study was to investigate the role of blood biomarkers as prognostic predictors in the patients with RA-UIP.METHODS: The blood levels of biomarkers (Krebs von den Lungen-6 [KL-6], surfactant protein-A [SP-A], matrix metalloproteinase-7 [MMP-7], interleukin-6 [IL-6], and interleukin-32 [IL-32]) were retrospectively compared with the clinical courses of 62 patients with RA-UIP.RESULTS: The median follow-up period was 33.4 months. RA-UIP progressed in 15 patients (45.2%) during one year of follow-up. We found that KL-6 and IL-6 were significant predictors of short-term (1 year) prognosis. Multivariate logistic regression analysis showed that the odds ratio (OR) for KL-6 was 1.001 (95% confidence interval [CI]: 1.000-1.003, p = 0.077) and that the OR for IL-6 was 1.040 (95% CI: 1.002-1.080, p = 0.039) for short-term disease progression. The addition of KL-6 and IL-6 to the clinical parameters (concordance index [C-index]: 0.958, p = 0.053) predicted short-term disease progression better than the clinical parameter alone (C-index: 0.853). In addition, patients with high levels of KL-6 (≥933 U/mL) had shorter survival than those with low levels of KL-6 (<933 U/mL) (median survival: 51 vs. 96 months, p = 0.019).CONCLUSIONS: The results of this retrospective study suggested that KL-6 and IL-6 could be used as predictors of short-term disease progression. In addition, high levels of KL-6 could be used as a predictor of mortality. Additional studies involving a larger patient cohort are warranted.

KW - Biomarkers, Rheumatoid arthritis, Interstitial lung disease, Prognosis, KL-6, IL-6

UR - http://www.scopus.com/inward/record.url?scp=85015350757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015350757&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 216

EP - 223

JO - Sarcoidosis Vasculitis and Diffuse Lung Diseases

JF - Sarcoidosis Vasculitis and Diffuse Lung Diseases

SN - 1124-0490

IS - 3

ER -